FDA officials said the approach had sufficiently promising data from Chinese doctors in the recent epidemic in Wuhan
SILVER SPRING, Md.—The Food and Drug Administration has begun to allow doctors to treat some patients with the blood plasma of patients who have recovered from the coronavirus-caused Covid-19 disease.
The treatment must be approved on a case-by-case basis, and patients must meet certain conditions, the FDA said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA Approves Test That Could Detect Coronavirus In About 45 MinutesThe test will begin shipping next week with plans of using the product by the end of the month.
続きを読む »
FDA Approves More ‘Rapid’ COVID-19 Coronavirus Tests For Use On FrontlinesThe U. S. Food and Drug Administration is approving more rapid molecular diagnostic tests that can be used in temporary screening locations, doctor’s office labs and nursing homes to detect the Coronavirus strain COVID-19 in less than a half hour.
続きを読む »
FDA will allow doctors to treat critically ill coronavirus patients with blood from survivorsUnder new emergency protocols approved Tuesday, FDA will allow doctors across the US to begin using plasma donated by coronavirus survivors to treat patients who are critically ill with the virus.
続きを読む »
FDA Suspends Routine Food Inspections Amid Coronavirus PandemicAbout 77 percent of the U.S. food supply is regulated by the FDA
続きを読む »
FDA Approved Drugs Show Promise Against COVID-19Two promising new studies suggest that dozens of drugs already approved for use in the United States may prove effective against the new coronavirus.
続きを読む »